In vitro studies indicate that gliomas with a mutation of the isocitrate dehydrogenase (<i>IDH</i>) increase neuronal excitability of the peritumoral cortex, contributing to epileptogenesis in these patients. The gene discussed is IDH3A; the disease is central nervous system cancer.